Jeffrey Kirsch, MD, Professor and Chair, Department of Anesthesiology & Perioperative Medicine, was quoted in a New York Times article on the drug Cymbalta being approved for chronic pain. On Thursday, an advisory panel to the Food and Drug Administration voted 8-6 in favor of expanding approved uses of Cymbalta. According to the article, FDA officials assured the panel they would draft warnings against the overuse of Cymbalta for pain, if they did finally approve a label change. Dr. Kirsch, who is the chairman of the advisory panel, told the NY Times, “I think it will be a very useful drug for a significant number of patients.”

Read article at NY Times